2016
DOI: 10.2174/0929867323666160418114826
|View full text |Cite
|
Sign up to set email alerts
|

Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging

Abstract: The development of reversibly binding radioligands for imaging brain proteins in vivo, such as enzymes, neurotransmitter transporters, receptors and ion channels, with positron emission tomography (PET) is keenly sought for biomedical studies of neuropsychiatric disorders and for drug discovery and development, but is recognized as being highly challenging at the medicinal chemistry level. This article aims to compile and discuss the main considerations to be taken into account by chemists embarking on program… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
214
0
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 162 publications
(220 citation statements)
references
References 357 publications
(310 reference statements)
4
214
0
2
Order By: Relevance
“…Previously, we achieved an increase in LipE by introducing a nitrogen atom at either the 2’ position of the pendant phenyl group or the 8 position of the quinolinyl scaffold (Chart 2) [26]. We presumed that by having nitrogen atoms at both positions in the same ligand that we might significantly improve LipE, and, indeed, this turned out to be the case in ligand 20 (Table 1).…”
Section: Resultsmentioning
confidence: 91%
See 2 more Smart Citations
“…Previously, we achieved an increase in LipE by introducing a nitrogen atom at either the 2’ position of the pendant phenyl group or the 8 position of the quinolinyl scaffold (Chart 2) [26]. We presumed that by having nitrogen atoms at both positions in the same ligand that we might significantly improve LipE, and, indeed, this turned out to be the case in ligand 20 (Table 1).…”
Section: Resultsmentioning
confidence: 91%
“…These modifications were aimed at exploring, i) variation of substituents on the amide nitrogen, ii) introduction of nitrogen into the quinolin-4-yl group or pendant aryl ring, iii) replacement of the pendant aryl ring with methoxy, 2-pyrimidinyl or N -pyrrolidinyl, iv) the effect of cyclization to eliminate amide bond rotation, and v) contraction of the bicyclic quinolinyl nucleus. Generally, PET radioligands are required to have high affinity with K D in the low nM range, and moderate lipophilicity with measured (or computed) logD in the 2–4 range [26]. Most of the changes that we made to the lead ligand scaffold were intended to retain the very high TSPO affinity ( K i = 0.07 nM for rat TSPO) seen in the previously reported example 11 (Chart 2; scaffold with Y = 2-pyridinyl, and R = Ph), as well as to decrease ligand computed lipophilicity (clog D ) from 4.73 towards the desirable range.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…6365 The cLog P values of compounds 8 - 11 were predicted to be 2.90, 2.90, 2.80 and 2.80, respectively (Table 1). Using liquid-liquid partition between n -octanol and water (‘shake flask method’), 66 the Log P values for 8 - 11 were determined to be 1.45 ± 0.01, 1.42 ± 0.11, 1.23 ± 0.10 and 1.17 ± 0.14, respectively ( n = 3).…”
Section: Resultsmentioning
confidence: 99%
“…The development of a successful PET biomarker is a much more challenging problem, which whilst requiring the equivalent radiochemistry expertise also includes many other complexities surrounding the compound to radiolabel. This is like a mini drug development programme in itself with the compound needing appropriate characteristics such that it readily crosses the BBB, binds with high enough affinity and selectivity to the biological target, low enough non-specific binding so background signal does not dominate and suitable kinetics so that an appropriate outcome measure can be estimated [57,58]. Since the first development of radioligands for GPCR targets in the late 80's, initial screening of compounds has focussed on identifying those with suitable lipophilicty (typically Log P 1-3) to ensure BBB penetration and nM or better affinity to yield signal at the target.…”
Section: Biomarker Developmentmentioning
confidence: 99%